docturnal Company

Docturnal offers custom content for diabetes, heart, cancer, Autism, and Arthritis for users who have a condition or their concerned ones. The company is a point of care screening and diagnostics provider of non-invasive and proactive detection of diseases. Docturnal’s product portfolio also includes solutions for CoPD and Asthma with a pipeline of lung based ailments that can be identified by an aural component. Docturnal products are designed to make detection of diseases easy and hassle-free. Essentially it means being accessible and affordable to the last mile. Docturnal was established in April 2016.
Technology: Сancer Diagnostics
Industry: P4 Medicine
Headquarters: Hyderabad, Andhra Pradesh, India
Zip: 1-10
Founded Date: 2016-04-01
Employees Number: 1-10
Funding Status: Seed
Acquisitions Number: 7
Investors Number: 147425
Total Funding: $1M to $10M
Estimated Revenue: $1M to $10M
Last Funding Date: Seed
Last Funding Type:

Visit Website
Register and Claim Ownership